Checkpoint Kinase (Chk)

Checkpoint Kinase (Chk)(细胞周期检查点激酶)

Checkpoint Kinases (Chk) are protein kinases that are involved in cell cycle control. Two checkpoint kinase subtypes have been identified, Chk1 and Chk2. Chk1 is a central component of genome surveillance pathways and is a key regulator of the cell cycle and cell survival. Chk1 is required for the initiation of DNA damage checkpoints and has recently been shown to play a role in the normal (unperturbed) cell cycle. Chk1 impacts various stages of the cell cycle including the S phase, G2/M transition and M phase. In addition to mediating cell cycle checkpoints, Chk1 also contributes to DNA repair processes, gene transcription, embryo development, cellular responses to HIV infection and somatic cell viability. Chk2 is a protein kinase that is activated in response to DNA damage and is involved in cell cycle arrest. In response to DNA damage and replication blocks, cell cycle progression is halted through the control of cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor.

Checkpoint Kinase (Chk) 相关产品(32)

  • GC50119 structure
    GC50119AZD 7762 hydrochloride
    CAS: 1246094-78-9

    A selective checkpoint kinase inhibitor

  • GC60698 structure
    GC60698Chk1-IN-5
    CAS: 2120398-39-0

    Chk1-IN-5是有效的检查点激酶1(Chk1)抑制剂。Chk1-IN-5抑制Chk1磷酸化,并在结肠癌异种移植模型中抑制肿瘤生长。

  • GC62986 structure
    GC62986GDC-0425
    CAS: 1200129-48-1
    纯度: >99.00%

    GDC-0425 (RG-7602) 是一种有效的、具有口服活性的、高选择性的 ChK1 抑制剂。GDC-0425 可用于多种恶性肿瘤的研究。

  • GC65435 structure
    GC65435Monalizumab
    CAS: 1228763-95-8
    纯度: >99.00%

    Monalizumab 是一种首创的靶向自然杀伤细胞群 2A (NKG2A) 的免疫检查点抑制剂。Monalizumab 是一种人源化抗 NKG2A 的单克隆抗体,可增加 IFN-γ 产生,从而促进自然杀伤细胞功能。Monalizumab 可用于头颈部鳞状细胞癌 (HNSCC) 的研究。

  • GC72784 structure
    GC72784VRX0466617
    CAS: 926906-64-1
    纯度: >99.00%

    VRX0466617一种选择性Chk2抑制剂,抑制Chk2-Ser 19和Ser33-35的磷酸化。

  • GC72958 structure
    GC72958PV-1019
    CAS: 1093793-05-5
    纯度: >99.00%

    PV-1019(NSC 744039)是一种有效的选择性Chk2抑制剂,IC50值为24 nM。

  • GC72986 structure
    GC72986CHK1-IN-4 hydrochloride
    纯度: 不显示

    CHK1-IN-4 hydrochloride(化合物3)是一种强效的检查点激酶1(chk1)抑制剂,能有效抑制肿瘤细胞中的chk1磷酸化。

  • GC73822 structure
    GC73822GNE-900
    CAS: 1200126-26-6
    纯度: >99.00%

    GNE-900是一种ATP竞争性、选择性和口服活性的ChK1抑制剂,ChKl和ChK2的IC50分别为0.0011和1.5µM。